Investment Uncut: What if we cure obesity?

You can listen to our podcasts online via the player below or search for 'Investment Uncut' and review, rate and subscribe on Apple Podcasts, Spotify, Pocket Casts or SoundCloud.

In this feature episode, Letty talks to Dr Jonathan Pearson-Stuttard, Head of LCP Health and Stuart McDonald, Head of Longevity and Demographic Insights on the topic of obesity. Together they ask: what if we really could cure obesity?

Breakthroughs in weight-loss treatments could have far-reaching consequences beyond pharmaceuticals, reshaping healthcare spending, longevity, consumer behaviour and investment opportunities. This discussion explores what's realistically achievable over the next decade, who would bear the costs and reap the benefits, and whether longer, healthier lives could create financial challenges for pension schemes?

We’ll consider the overlooked implications for businesses and investors, separating plausible developments from optimistic narratives and identifying what to watch next. 

What’s one thing you would like listeners to take away?

• Investing in prevention and treating health as an asset could help shift healthcare towards a more proactive model, potentially creating opportunities such as health bonds. However, while anti-obesity medicines offer promise, claims that they will drive dramatic increases in life expectancy remain premature.